Stefan Pöhlmann

Head of Infection Biology Unit

German Primate Center

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Stefan Pöhlmann is the Head of the Infection Biology Unit at the German Primate Center in Germany. His research focuses on viral entry pathways, immune response to SARS-CoV-2 variants, and the development of antiviral strategies. He has recently published articles on the mechanisms of entry for various SARS-CoV-2 sublineages and the interaction of nanoparticles with viral processes.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Nadine Krüger

Head of Unit

German Primate Center

GERMANY

View details

Gavin Miller

Professor of Biological Chemistry

Keele University

UNITED KINGDOM

View details

Dejian Zhou

Professor of Nanochemistry

University of Leeds

UNITED KINGDOM

View details

Stefan A. Laufer

Eberhard Karls Universität Tübingen

GERMANY

View details

Hans-Martin Jäck

Director and Professor of Immunology

University of Erlangen-Nuremberg

GERMANY

View details

Thanigaimalai Pillaiyar

Eberhard Karls Universität Tübingen

GERMANY

View details

Thales Kronenberger

GERMANY

View details

Michael Winkler

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stefan Pöhlmann

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Polyvalent Mannuronic Acid-Coated Gold Nanoparticles for Probing Multivalent Lectin–Glycan Interaction and Blocking Virus Infection

Entry Efficiency, Protease Dependence, and Antibody-Mediated Neutralization of SARS-CoV-2 Sublineages KP.3.1.1 and XEC

Amino acid residues 655 and 969 in the spike protein of Omicron subvariant BA.1 control use of TMPRSS2 versus Cathepsin L dependent entry pathways and cell tropism

Simulations and active learning enable efficient identification of an experimentally-validated broad coronavirus inhibitor

Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage

Diversification of the VH3‐53 immunoglobulin gene segment by somatic hypermutation results in neutralization of SARS‐CoV‐2 virus variants

Interferon-Stimulated Genes that Target Retrovirus Translation

Development of rhesus macaque astrocyte cell lines supporting infection with a panel of viruses

The Inhibition of Gag-Pol Expression by the Restriction Factor Shiftless Is Dispensable for the Restriction of HIV-1 Infection

Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany

SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency

Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1

Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients

Development of immortalized rhesus macaque kidney cells supporting infection with a panel of viruses

Discovery of Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for COVID-19

Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage

Collaborators (8)

Nadine Krüger

Gavin Miller

Dejian Zhou

Stefan A. Laufer

Hans-Martin Jäck

Thanigaimalai Pillaiyar

Thales Kronenberger

Michael Winkler

Make your next move.